Krispy Kreme, a former "cult" stock, expanded too quickly in the early 2000s, and nearly went under as a result of poor accounting practices, and bad management.
After closing stores, and retrenching over the years, the company has focused on growing again, primarily through franchising in international markets.
The doughnut maker currently has about 240 U.S. locations, and 500 international. It also has plans to grow to 400 US locations, and 900 international by 2017. This is not the same company it was 10 years ago.
It will open its' first store in India later this week, and has plans for a total of 80 in that country.As of the latest fiscal year-end, there were 87 stores in Saudi Arabia, 71 in Mexico, 34 in Japan, and 56 in South Korea, 48 in the UK and the list of international locations continues data by YCharts
The recent run-up in share price may be due to some takeover speculation, although there's been nothing concrete. However, the company's adoption of a "tax asset protection plan," otherwise known as a "poison pill" early this week, lends some credence to the that speculation. The plan "discourages" new investors from taking more than a 4.99% stake in the company, and its stated intention is to preserve the value of the company's operating loss carry forwards, which for federal alone, amount to $240 million. Existing 4.99% or greater shareholders are exempt from the poison pill at current ownership levels, but not if they increase their stakes. As a Krispy Kreme shareholder, I'm not a fan of this poison pill, or for that matter, poison pills in general. It's a tale of two companies; one that wants to be sold and another that apparently does not. This should make for some interesting story lines for 2013. Now, as I type this on my Dell, I could really go for a Krispy Kreme...or two. At the time of publication the author is long KKD. Follow @JonMHellerCFA This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts